Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1313

    1.

    Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil.

    Bottecchia M, Souto FJ, O KM, Amendola M, Brandão CE, Niel C, Gomes SA.

    BMC Microbiol. 2008 Jan 22;8:11.PMID: 18211717 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients.

    Ramos B, Núñez M, Martín-Carbonero L, Sheldon J, Rios P, Labarga P, Romero M, Barreiro P, García-Samaniego J, Soriano V.

    J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):557-61.PMID: 17224847 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Determination of hepatitis B virus genotype and detection of lamivudine-resistance mutations]

    Nogales MC, Serrano MC, Suárez E, Corpas R, Pérez L, Claro R, Jarana R, Romero-Gómez M, Martín-Mazuelos E.

    Gastroenterol Hepatol. 2004 Nov;27(9):515-20. Spanish. PMID: 15544736 [PubMed - indexed for MEDLINE]Related articles

    4.

    The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.

    Paik YH, Han KH, Hong SP, Lee HW, Lee KS, Kim SO, Shin JE, Ahn SH, Chon CY, Moon YM.

    Antivir Ther. 2006;11(4):447-55.PMID: 16856618 [PubMed - indexed for MEDLINE]Related articles

    5.

    Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan.

    Suzuki F, Tsubota A, Arase Y, Suzuki Y, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kobayashi M, Matsuda M, Satoh J, Takagi K, Kumada H.

    Intervirology. 2003;46(3):182-9.PMID: 12867757 [PubMed - indexed for MEDLINE]Related articles

    6.

    Viral features of lamivudine resistant hepatitis B genotypes A and D.

    Zöllner B, Petersen J, Puchhammer-Stöckl E, Kletzmayr J, Sterneck M, Fischer L, Schröter M, Laufs R, Feucht HH.

    Hepatology. 2004 Jan;39(1):42-50.PMID: 14752821 [PubMed - indexed for MEDLINE]Related articles

    7.

    Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.

    Pan XP, Li LJ, Du WB, Li MW, Cao HC, Sheng JF.

    J Viral Hepat. 2007 Nov;14(11):767-74.PMID: 17927612 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine.

    Santos EA, Sucupira MV, Arabe J, Gomes SA.

    BMC Infect Dis. 2004 Aug 31;4:29.PMID: 15339340 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.

    Wakil SM, Kazim SN, Khan LA, Raisuddin S, Parvez MK, Guptan RC, Thakur V, Hasnain SE, Sarin SK.

    J Med Virol. 2002 Nov;68(3):311-8.PMID: 12226816 [PubMed - indexed for MEDLINE]Related articles

    10.

    Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy.

    Kazim SN, Chauhan R, Das BC, Sarin SK.

    J Gastroenterol Hepatol. 2006 Oct;21(10):1525-32.PMID: 16928212 [PubMed - indexed for MEDLINE]Related articles

    11.

    Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantation.

    Ben-Ari Z, Ashur Y, Daudi N, Shmilovitz-Wiess H, Brown M, Sulkes J, Klein A, Mor E, Tur-Kaspa R, Shouval D.

    Clin Transplant. 2004 Aug;18(4):415-22.PMID: 15233819 [PubMed - indexed for MEDLINE]Related articles

    12.

    Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.

    Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S.

    J Med Virol. 2007 Nov;79(11):1664-70.PMID: 17854034 [PubMed - indexed for MEDLINE]Related articles

    13.

    Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: a single center experience.

    Sun J, Wang Z, Ma S, Zeng G, Zhou Z, Luo K, Hou J.

    J Med Virol. 2005 Mar;75(3):391-8.PMID: 15648063 [PubMed - indexed for MEDLINE]Related articles

    14.

    Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.

    Dai CY, Chuang WL, Hsieh MY, Lee LP, Huang JF, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML.

    Antiviral Res. 2007 Aug;75(2):146-51. Epub 2007 Mar 16.PMID: 17400303 [PubMed - indexed for MEDLINE]Related articles

    15.

    Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B.

    Quarleri J, Moretti F, Bouzas MB, Laufer N, Carrillo MG, Giuliano SF, Pérez H, Cahn P, Salomon H.

    AIDS Res Hum Retroviruses. 2007 Apr;23(4):525-31.PMID: 17506609 [PubMed - indexed for MEDLINE]Related articles

    16.

    Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan.

    Hayashi K, Katano Y, Takeda Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Nakano I, Yano M, Goto H, Yoshioka K, Toyoda H, Kumada T.

    J Med Virol. 2007 Apr;79(4):366-73.PMID: 17311332 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine.

    Amini-Bavil-Olyaee S, Hosseini SY, Sabahi F, Alavian SM.

    Int J Infect Dis. 2008 Jan;12(1):83-7. Epub 2007 Aug 14.PMID: 17698384 [PubMed - indexed for MEDLINE]Related articles

    19.

    Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico.

    Alvarado-Esquivel C, de la Ascensión Carrera-Gracia M, Conde-González CJ, Juárez-Figueroa L, Ruiz-Maya L, Aguilar-Benavides S, Torres-Valenzuela A, Sablon E.

    J Antimicrob Chemother. 2006 Feb;57(2):221-3. Epub 2005 Dec 22.PMID: 16373428 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Genotypic and phenotypic resistance: longitudinal and sequential analysis of hepatitis B virus polymerase mutations in patients with lamivudine resistance after liver transplantation.

    Ben-Ari Z, Daudi N, Klein A, Sulkes J, Papo O, Mor E, Samra Z, Gadba R, Shouval D, Tur-Kaspa R.

    Am J Gastroenterol. 2003 Jan;98(1):151-9.PMID: 12526951 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination